Virus Genome Detection – HIV-1 Drug Resistance Determination – Standard Program for Protease and Reverse Transcriptase Inhibitors
[Virusgenom-Nachweis – HIV-1 Resistenzbestimmung – Standardprogramm für Protease- und Reverse-Transkriptase-Inhibitoren]
EPTIS factsheet 437279 | Last revision 2019-03-12 | URL: https://www.eptis.bam.de/pts437279 https://www.eptis.bam.de/pts437279
| PT provider | |||||||
| PT provider | INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories | ||||||
| Based in | Germany | ||||||
| Language(s) | German, English | ||||||
| Remarks | Please note: The samples can contain plasmids and heat-inactivated cell culture supernatant viruses respectively! The INSTAND EQA schemes in virology are carried out in scientific cooperation with the Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten (DVV e.V.), Gesellschaft für Virologie (GfV e.V.) and Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM e.V.). The characterization of the EQA samples including the determination of the target values/consensus values is carried out in cooperation with the INSTAND Expert laboratories. Cooperation with: Nationales Referenzzentrum für Retroviren, Max von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, München; Institut für Medizinische Virologie, Uniklinikum Frankfurt am Main; Institut für Klinische und Molekulare Virologie, Uniklinikum Erlangen; Nationales Referenzzentrum für Papillom- und Polyomaviren, Institut für Virologie, Uniklinik Köln; Medizinisches Infektiologiezentrum Berlin Information for 2019 (for details please see www.instand-ev.de -> EQAS and EQAS Online) | ||||||
| Keywords | |||||||
| Product groups |
Human test material
|
||||||
| Testing fields |
Medical analysis
|
||||||
| Technical details | |||||||
|
|||||||
| Aims of the PT scheme | |||||||
| Target group of participants | |||||||
| Linked to specific legislation / standards | |||||||
| Additional, subsidiary aims | |||||||
| Number of participants | < 50 | ||||||
| Accredited or otherwise reviewed by a 3rd party |
Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043 |
||||||
| Operation is commissioned / requested by | German Bundesärztekammer (General medical Council) | ||||||
| Fees and frequency | |||||||
| Participation fee | 595 Euro / Survey | ||||||
| Regularly operated | Yes (1 time per year) | ||||||
| Year of first operation | Experience with operation of ILCs since 1968 | ||||||
| Contact details of the PT provider | |||||||
| Provider | Contact person | ||||||
|
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20 40223 Düsseldorf Germany Phone: +49-211-159213-0 Fax: +49-211-159213-30 Web: http://www.instandev.de/ http://www.instandev.de/ |
Dr. rer. nat. Nathalie Wojtalewicz
Phone: +49-211-15921341 Fax: +49-211-15921330 Email: wojtalewicz@instand-ev.de wojtalewicz@instand-ev.de |
||||||